Kapoor John N
SEC-identified person · CIK 1033150 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Insys Therapeutics, Inc. INSY | Director | filed 2013 - 2018 |
| Akorn INC AXRX | Director | filed 2006 - 2018 |
| Neopharm INC NEOL.PK | Director · Chairman of the Board | filed 2006 - 2009 |
| Introgen Therapeutics INC ingn | Director | filed 2006 - 2008 |
| Option Care INC/DE OPTN | Director | filed 2006 - 2007 |
| Sciele Pharma, INC. SLRX | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.